Live Breaking News & Updates on Tiziana Life Sciences Ltd Nasdaq

Stay updated with breaking news from Tiziana life sciences ltd nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tiziana Life Sciences (TLSA) Receives Grant by the Brigham and Women's Hospital to Explore anti-CD3 mAb

Tiziana Life Sciences (TLSA) Receives Grant by the Brigham and Women's Hospital to Explore anti-CD3 mAb
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hana Malik , Howardl Weiner , Gabriele Cerrone , Mattheww Davis , Barnett Drug Development Grant , Irina Kofflerlifesci Advisors , Tiziana Life Sciences , Tiziana Life Sciences Ltd , Tiziana Life Sciences Ltd Nasdaq , Lawrence Isabel Barnett Drug Development Program Grant , Isabel Barnett Drug Development Program , Association Barnett Drug Development , Ann Romney Center , Business Development , Wall Street , Life Sciences Ltd , Isabel Barnett Drug Development Program Grant , Neurologic Diseases , Amyotrophic Lateral Sclerosis , Scientific Advisory Board , Executive Chairman , Chief Executive Officer , Central Nervous System , Chief Medical Officer , Barnett Drug Development , Life Sciences ,

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer

NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.(Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug ....

Irina Koffler , Matthew Davis , Hana Malik , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Tiziana Life Sciences Ltd Nasdaq , Business Development , Life Sciences Ltd , Chief Medical Officer , Life Sciences , Investor Relations , Sci Advisors ,

Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer

Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announces that it has been notified that Matthew Davis, its Chief Medical Officer, purchased 100,000 common shares at $0.76 per share . ....

Matthew Davis , Tiziana Life Sciences Ltd Nasdaq , Life Sciences Ltd , Chief Medical Officer ,

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd.(Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug ....

Irina Koffler , Hana Malik , Gabriele Cerrone , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Tiziana Life Sciences Ltd Nasdaq , Panetta Partners , Business Development , Life Sciences Ltd , Panetta Partners Limited , Executive Chairman , Life Sciences , Investor Relations , Sci Advisors ,

Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gabriele Cerrone , Tiziana Life Sciences Ltdhana Malik , Tiziana Life Sciences Ltd , Tiziana Life Sciences Ltd Nasdaq , Irina Kofflerlifesci Advisors , Panetta Partners , Tiziana Life Sciencestiziana Sciences , Business Development , Life Sciences Ltd , Panetta Partners Limited , Executive Chairman , Life Sciences Ltdhana Malik , Investor Relations Manager , Tiziana Life Sciences ,